PSNC News Latest News
COVID-19 Funding Update: Ministers agree £300 million cash injection
Ministers have agreed to inject a total of £300 million of advance funding into community pharmacies over the next two...
National bodies urge public to treat high street pharmacy teams with respect
Patients are today being asked to treat high street pharmacy staff with respect, as they deliver vital support on the...
Shortage Notice: Salofalk (mesalazine) suppositories (500mg and 1g) – Update
Update (30/03/2020): 500mg suppositories now in stock, 1g suppository due back late July 2020. First published 24th October 2019 Dr...
Class 4 Medicines Defect Information: Paracetamol 250mg/5ml Oral Suspension 500ml (Rosemont Pharmaceuticals Ltd)
Class 4 Medicines Defect Information – Paracetamol 250mg/5ml Oral Suspension 500ml (Rosemont Pharmaceuticals Ltd) Drug alert number: (EL(20)A/19) Date issued:...
COVID-19: PSNC Negotiations Update
PSNC has today (27th March) published a list of the possible action points that we are in urgent negotiations with...
Pharmacy bodies publish resilience guidance to support pharmacy teams
PSNC, working closely with NPA, CCA and AIM, has published guidance to help support and maintain the community pharmacy network...
Class 4 Medicines Defect Information: Zamadol SR 50 mg prolonged-release hard capsules (Mylan UK Healthcare Ltd)
Class 4 Medicines Defect Information – Zamadol SR 50 mg prolonged-release hard capsules (Mylan UK Healthcare Ltd) Drug alert number:...
Contractor Notice: SSP04: Haloperidol 500mcg capsules expired
Following the implementation of SSP04, DHSC has announced that sufficient stock of Haloperidol 500mcg capsules is now available to supply...
COVID-19: Communications and a message from PSNC’s CEO
PSNC Chief Executive Simon Dukes has recorded a video message for community pharmacy teams to explain the work that he...
